Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / SHRT HGH YIELD
-
Total 13F shares
-
2,063,795
-
Share change
-
+1,241,576
-
Total reported value
-
$33,501,872
-
Price per share
-
$16.12
-
Number of holders
-
18
-
Value change
-
+$20,235,429
-
Number of buys
-
11
-
Number of sells
-
9
Institutional Holders of PROSHARES TR - SHRT HGH YIELD (SJB) as of Q1 2025
As of 31 Mar 2025,
PROSHARES TR - SHRT HGH YIELD (SJB) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,063,795 shares.
The largest 10 holders included
Csenge Advisory Group, FOURPATH CAPITAL MANAGEMENT, LLC, STABLEFORD CAPITAL II LLC, CITIZENS FINANCIAL GROUP INC/RI, Solstein Capital, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Park Square Financial Group, LLC, Elevated Capital Advisors, LLC, CITADEL ADVISORS LLC, and Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors.
This page lists
18
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.